706 related articles for article (PubMed ID: 27856628)
1. Analysis of Extrastriatal
Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
[No Abstract] [Full Text] [Related]
2. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
3. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
4. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
[TBL] [Abstract][Full Text] [Related]
5. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
[TBL] [Abstract][Full Text] [Related]
6. Preserved Extrastriatal
Nicastro N; Burkhard PR; Garibotto V
Mol Imaging Biol; 2020 Dec; 22(6):1592-1599. PubMed ID: 32468408
[TBL] [Abstract][Full Text] [Related]
7. Test-retest reproducibility of extrastriatal binding with
Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T
Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458
[No Abstract] [Full Text] [Related]
8. Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
Joling M; van den Heuvel OA; Berendse HW; Booij J; Vriend C
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):89-94. PubMed ID: 28899958
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
10. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
Lee H; Sung YH; Hwang KH
Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
[TBL] [Abstract][Full Text] [Related]
11. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An
van der Zande JJ; Joling M; Happach IG; Vriend C; Scheltens P; Booij J; Lemstra AW
Neuroimage Clin; 2020; 25():102062. PubMed ID: 31790878
[TBL] [Abstract][Full Text] [Related]
13. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
[TBL] [Abstract][Full Text] [Related]
14. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
15. Extrastriatal
Nicastro N; Garibotto V; Burkhard PR
BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
[TBL] [Abstract][Full Text] [Related]
16. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.
Kim YJ; Ichise M; Ballinger JR; Vines D; Erami SS; Tatschida T; Lang AE
Mov Disord; 2002 Mar; 17(2):303-12. PubMed ID: 11921116
[TBL] [Abstract][Full Text] [Related]
17. Assessing the optimal time point for the measurement of extrastriatal serotonin transporter binding with 123I-FP-CIT SPECT in healthy, male subjects.
Koopman KE; la Fleur SE; Fliers E; Serlie MJ; Booij J
J Nucl Med; 2012 Jul; 53(7):1087-90. PubMed ID: 22627000
[TBL] [Abstract][Full Text] [Related]
18. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.
Brücke T; Asenbaum S; Pirker W; Djamshidian S; Wenger S; Wöber C; Müller C; Podreka I
J Neural Transm Suppl; 1997; 50():9-24. PubMed ID: 9120429
[TBL] [Abstract][Full Text] [Related]
20. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
